Oral Cancer Treatment Market size was over USD 2.2 billion in 2024 and is estimated to reach USD 4.7 billion by the end of 2037, expanding at a CAGR of 6.7% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of the oral cancer treatment is assessed at USD 2.3 billion.
The need for early detection to prevent the severity and fatality of oral cancer is one of the major driving factors in this industry. Innovative methods and tools such as biomarkers, imaging techniques, and genetic profiling for advanced diagnosis have helped to offer better treatment outcomes. This further accelerates the technological progress of this sector to introduce more diagnostic tools.
Many companies and research institutions are now collaborating to develop new technologies for early detection. For instance, in August 2024, a chemical engineering team from IIT Kapur passed their newly discovered portable oral detection device, Munh-Parikshak to Scangenie Scientific Pvt. Ltd. for commercialization. The non-invasive kit can be wirelessly connected to smartphones, tablets, and iPads to display its 90% accurate screening results. Such developments are encouraging healthcare companies to invest in R&D projects to produce more revolutionary solutions. This is also propelling the demand for preventive diagnostic solutions in the oral cancer treatment market.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.7% |
|
Base Year Market Size (2024) |
USD 2.2 billion |
|
Forecast Year Market Size (2037) |
USD 4.7 billion |
|
Regional Scope |
|
Application (Hospitals and Clinics, Research Organizations, Academic Institutes)
Hospitals and clinics segment is predicted to account for around 57.4% oral cancer treatment market share by 2037. The growth in this segment is driven by the availability of therapeutics, surgical interventions, and various therapies under one roof. This multidisciplinary approach of cancer care centers ensures comprehensive care of patients, encouraging more investment in this sector. The wide range of facilities including diagnosis, surgery, chemotherapy, and rehabilitation helps these institutions to establish steady growth. Rising oral cancer incidences have also inflated the frequency of hospital admissions for treatment, which shows the potential for this segment to grow higher.
Product Type (Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas)
Based on product type, the squamous cell carcinoma segment is predicted to generate remarkable revenues in the oral cancer treatment market. Innovation in immunotherapy has created new paradigms to offer better outcomes in advanced cases. Recently developed biologic agents and checkpoint inhibitors have opened new possibilities for recovering critical-stage patients. Increased survival rates due to advancements in early detection are also encouraging companies or research centers to develop new technologies such as liquid biopsies and enhance imaging techniques. For instance, in May 2o21, Viome launched an FDA-approved oral and throat cancer detection tool, based on its patented metatranscriptomics and AI platform. The screening test can detect OSCC and OPC by making saliva a liquid biopsy.
Our in-depth analysis of the market includes the following segments:
|
Application |
|
|
Product Type |
|
|
Treatment |
|
North America Market Analysis
North America oral cancer treatment market is anticipated to dominate revenue share of around 51% by the end of 2037. The region is witnessing significant growth due to its well-established healthcare infrastructure. This has further brought advancements in treatment modalities through innovative solutions. The evaluating medical industry of this region is now focusing on providing remote testing facilities to ensure early testing. For instance, in August 2022, Viome launched an FDA-approved at-home oral and throat cancer testing platform, CancerDetect. This saliva-based diagnostic platform is equipped with AI and Mrna technology to deliver 95% specificity and 90% sensitivity rates.
The U.S. is estimated to hold a large value in the oral cancer treatment market by the end of 2037 due to the increasing incidences of oral cancer. The country has noticed the deteriorating survival rate of patients due to late diagnosis. According to a study conducted by NLM in June 2022, around 70% of oral cancer cases are diagnosed at later stages in this country. This further reduced the 5-year survival rate from 83.7% tested in earlier stages to 38.5% when the cancer had metastasized. Such surveys show the importance of adopting advanced testing to improve patient outcomes.
Canada is presenting a great scope of development in the oral cancer treatment market due to growing awareness of oral cancer risks. The country has now put its focus on precise medicine to offer better and more personalized treatment options for patients. The improved patient outcomes have further propelled the need for innovating effective methods of screening and rehabilitation. The domestic healthcare landscape is now adopting advanced technologies such as fluorescence and endoscopic imaging, minimally invasive surgeries, and proton therapy.
APAC Market Statistics
The Asia Pacific oral cancer treatment market is gaining traction due to rapid changes in lifestyle in developing countries. The incidence rate of oral malignancies has increased due to excessive consumption of alcohol, cigarettes, and other tobacco products. This is further contributing to heightening the demand for effective treatments and therapies. Well-developed countries such as Japan, Australia, and South Korea have built healthcare systems to support the inflating rate of prevalence. Both the private and public authorities are now focusing on building specialized fields of expertise to enable access to treatment for urban regions. This is encouraging more companies to invest in this sector.
India is experiencing a major increase in oral cancer incidences, particularly in the youth generation. According to a report published by WHO, in May 2024, around 3600 people die each day due to tobacco consumption in this country. The report further states, that tobacco usage among children aged between 13-15 accounted to be 8.4% in 2019. As a result, the fatalities and casualties of oral carcinomas are setting new records every year. The government of India has stepped in to control consumption and introduce treatments to save future generations. This is further increasing demand in the oral cancer treatment market.
China is also developing its healthcare infrastructure and investing heavily to bring development in the domestic oral cancer treatment market. Authorities are running awareness campaigns to promote early detection to improve survival rates. The programs are further extended to target tobacco and alcohol consumption to reduce incidence rates of oral cancer. The country is adopting biologics, immunotherapies, and personalized medicines, expanding the industry. Leading pharmaceutical companies are solidifying their presence to capture such a consumer base.
The current dynamics of the oral cancer treatment market are changing due to the integration of advanced technologies such as AI and cloud-based platforms. These are increasing the effectiveness of available treatments and therapies for the patients. For instance, in March 2023, IJNRD released a research paper on the usage of artificial intelligence in oral medical oncology and CDSS. The journal further states that chatbots and virtual assistants can help clinical professionals suggest the most effective treatment options. Such innovations are encouraging global leaders to expand their reach by introducing new therapeutics. Such key players in the market include:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?